The Non-Motor Symptoms Questionnaire (NMSQuest)1 was designed by a multi-disciplinary group of experts, including patient group representatives, for use as a screening tool for non-motor symptoms.3 It specifically focuses on non-motor symptoms in order to initiate further investigation.3 The NMSQuest is a valid instrument for use in the PD population, and has been used to study the spectrum of non-motor symptoms and their prevalence – showing that non-motor symptoms are very common across all stages of PD.3
The Non-Motor Symptom Scale (NMSS) was designed to address the problem, at the time, that there was no validated clinical tool to assess the progress of non-motor symptoms, or track their response to potential treatment.2 The 30-item NMSS was developed as a quick (10–15 minutes), easy to administer scale of non-motor symptoms, where the patient with PD is scored for both severity and frequency.2 When the NMSS was tested in patients with PD, its scores correlated with the severity of PD symptoms assessed using the Hoehn & Yahr scale, NMSQuest, and MDS-UPDRS Part I (which also measures non-motor symptoms) and, importantly, other health-related quality of life assessments.2,4 Development of instruments of this kind, which specifically analyse non-motor symptoms, allows for the evidence-based treatment of the non-motor symptom complex of PD.2
